BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10582585)

  • 1. Staurosporine-induced activation of caspase-3 is potentiated by presenilin 1 familial Alzheimer's disease mutations in human neuroglioma cells.
    Kovacs DM; Mancini R; Henderson J; Na SJ; Schmidt SD; Kim TW; Tanzi RE
    J Neurochem; 1999 Dec; 73(6):2278-85. PubMed ID: 10582585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress.
    Terro F; Czech C; Esclaire F; Elyaman W; Yardin C; Baclet MC; Touchet N; Tremp G; Pradier L; Hugon J
    J Neurosci Res; 2002 Aug; 69(4):530-9. PubMed ID: 12210846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease.
    Kim TW; Pettingell WH; Jung YK; Kovacs DM; Tanzi RE
    Science; 1997 Jul; 277(5324):373-6. PubMed ID: 9219695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of RNAi-mediated silencing of PEN-2, APH-1a, and nicastrin on wild-type vs FAD mutant forms of presenilin 1.
    Xie Z; Romano DM; Tanzi RE
    J Mol Neurosci; 2005; 25(1):67-77. PubMed ID: 15781968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing of wild-type and mutant familial Alzheimer's disease-associated presenilin-1 in cultured neurons.
    Weihl CC; Ghadge GD; Miller RJ; Roos RP
    J Neurochem; 1999 Jul; 73(1):31-40. PubMed ID: 10386952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase cleavage of exon 9 deleted presenilin-1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH-SY5Y neuroblastoma cells.
    Popescu BO; Cedazo-Minguez A; Popescu LM; Winblad B; Cowburn RF; Ankarcrona M
    J Neurosci Res; 2001 Oct; 66(1):122-34. PubMed ID: 11599009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of RNA interference-mediated silencing of gamma-secretase complex components on cell sensitivity to caspase-3 activation.
    Xie Z; Romano DM; Kovacs DM; Tanzi RE
    J Biol Chem; 2004 Aug; 279(33):34130-7. PubMed ID: 15184387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocapnia induces caspase-3 activation and increases Abeta production.
    Xie Z; Moir RD; Romano DM; Tesco G; Kovacs DM; Tanzi RE
    Neurodegener Dis; 2004; 1(1):29-37. PubMed ID: 16908971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis.
    Tanii H; Ankarcrona M; Flood F; Nilsberth C; Mehta ND; Perez-Tur J; Winblad B; Benedikz E; Cowburn RF
    Neuroscience; 2000; 95(2):593-601. PubMed ID: 10658639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of the presenilin 1/beta-catenin interaction and preservation of the heterodimeric presenilin 1 complex following caspase activation.
    Tesco G; Kim TW; Diehlmann A; Beyreuther K; Tanzi RE
    J Biol Chem; 1998 Dec; 273(51):33909-14. PubMed ID: 9852041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors.
    Miyoshi K; Ohyagi Y; Sakae N; Motomura K; Ma L; Taniwaki T; Furuya H; Tabira T; Kira J
    J Alzheimers Dis; 2009; 16(3):551-64. PubMed ID: 19276550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12.
    Chan SL; Culmsee C; Haughey N; Klapper W; Mattson MP
    Neurobiol Dis; 2002 Oct; 11(1):2-19. PubMed ID: 12460542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
    Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
    J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-apoptotic effect of presenilin 2 (PS2) overexpression is associated with down-regulation of Bcl-2 in cultured neurons.
    Araki W; Yuasa K; Takeda S; Takeda K; Shirotani K; Takahashi K; Tabira T
    J Neurochem; 2001 Dec; 79(6):1161-8. PubMed ID: 11752057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice.
    Wen PH; Hof PR; Chen X; Gluck K; Austin G; Younkin SG; Younkin LH; DeGasperi R; Gama Sosa MA; Robakis NK; Haroutunian V; Elder GA
    Exp Neurol; 2004 Aug; 188(2):224-37. PubMed ID: 15246822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presenilin 1 C92S mutation increases abeta 42 production.
    Lewis PA; Perez-Tur J; Golde TE; Hardy J
    Biochem Biophys Res Commun; 2000 Oct; 277(1):261-3. PubMed ID: 11027672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of wild-type presenilin 2 or its familial Alzheimer's disease-associated mutant does not induce or increase susceptibility to apoptosis in different cell lines.
    Gamliel A; Teicher C; Hartmann T; Beyreuther K; Stein R
    Neuroscience; 2003; 117(1):19-28. PubMed ID: 12605888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase cleaved presenilin-1 is part of active gamma-secretase complexes.
    Hansson CA; Popescu BO; Laudon H; Cedazo-Minguez A; Popescu LM; Winblad B; Ankarcrona M
    J Neurochem; 2006 Apr; 97(2):356-64. PubMed ID: 16539675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a familial Alzheimer's disease-linked presenilin-1 variant enhances perforant pathway lesion-induced neuronal loss in the entorhinal cortex.
    Lazarov O; Peterson LD; Peterson DA; Sisodia SS
    J Neurosci; 2006 Jan; 26(2):429-34. PubMed ID: 16407539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-type but not FAD mutant presenilin-1 prevents neuronal degeneration by promoting phosphatidylinositol 3-kinase neuroprotective signaling.
    Baki L; Neve RL; Shao Z; Shioi J; Georgakopoulos A; Robakis NK
    J Neurosci; 2008 Jan; 28(2):483-90. PubMed ID: 18184791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.